Long-term enzyme replacement therapy for Fabry disease: efficacy and unmet needs in cardiac and renal outcomes.
about
Clinical characteristics and mutation spectrum of GLA in Korean patients with Fabry disease by a nationwide survey: Underdiagnosis of late-onset phenotype.Biomarkers in Lysosomal Storage DiseasesGenetic variants associated with Fabry disease progression despite enzyme replacement therapy.Long-term outcomes with agalsidase alfa enzyme replacement therapy: Analysis using deconstructed composite events.Management of Bradyarrhythmias in Heart Failure: A Tailored Approach.
P2860
Long-term enzyme replacement therapy for Fabry disease: efficacy and unmet needs in cardiac and renal outcomes.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Long-term enzyme replacement t ...... in cardiac and renal outcomes.
@en
Long-term enzyme replacement t ...... in cardiac and renal outcomes.
@nl
type
label
Long-term enzyme replacement t ...... in cardiac and renal outcomes.
@en
Long-term enzyme replacement t ...... in cardiac and renal outcomes.
@nl
prefLabel
Long-term enzyme replacement t ...... in cardiac and renal outcomes.
@en
Long-term enzyme replacement t ...... in cardiac and renal outcomes.
@nl
P2093
P2860
P356
P1476
Long-term enzyme replacement t ...... in cardiac and renal outcomes.
@en
P2093
Beom Hee Lee
Eungu Kang
Gu-Hwan Kim
Han-Wook Yoo
Ja Hyang Cho
Ja Hye Kim
Jin-Ho Choi
P2860
P2888
P304
P356
10.1038/JHG.2016.78
P577
2016-06-23T00:00:00Z
P6179
1033086981